ID
13749
Description
Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01074047
Lien
https://clinicaltrials.gov/show/NCT01074047
Mots-clés
Versions (1)
- 02/03/2016 02/03/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
2 mars 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myeloid Leukemia NCT01074047
Eligibility Acute Myeloid Leukemia NCT01074047
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous cytotoxic or biologic treatment for aml (except hydroxyurea)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0023467
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [2]
- C0020402
Description
previous treatment with azacitidine, decitabine or cytarabine
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0004475
- UMLS CUI [1,2]
- C1514463
- UMLS CUI [2,1]
- C0049065
- UMLS CUI [2,2]
- C1514463
- UMLS CUI [3,1]
- C0010711
- UMLS CUI [3,2]
- C1514463
Description
prior use of targeted therapy agents (e.g., flt3 inhibitors, other kinase inhibitors)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2985566
- UMLS CUI [1,2]
- C1514463
Description
aml french american british subtype (fab m3)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
aml associated with inv(16), t(8;21), t(16;16), t(15:17), or t(9;22) karyotypes
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0023467
- UMLS CUI [1,2]
- C0008625
Description
prior bone marrow or stem cell transplantation
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0005961
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [2,1]
- C1504389
- UMLS CUI [2,2]
- C0332152
Description
candidate for allogeneic bone marrow or stem cell transplant
Type de données
boolean
Alias
- UMLS CUI [1]
- C0005961
- UMLS CUI [2]
- C1504389
Description
diagnosis of malignant disease within the previous 12 months (excluding base cell carcinoma, "in-situ" carcinoma of the cervix or breast or other local malignancy excised or irradiated with a high probability of cure)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
malignant hepatic tumors
Type de données
boolean
Alias
- UMLS CUI [1]
- C0345904
Description
uncontrolled systemic infection
Type de données
boolean
Alias
- UMLS CUI [1]
- C3646020
Description
active viral infection with human immunodeficiency virus (hiv) or hepatitis type b or c
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019682
- UMLS CUI [2]
- C0019163
- UMLS CUI [3]
- C0019196
Description
use of any experimental drug or therapy within 28 days prior to day 1
Type de données
boolean
Alias
- UMLS CUI [1]
- C0304229
Similar models
Eligibility Acute Myeloid Leukemia NCT01074047
- StudyEvent: Eligibility
C1515568 (UMLS CUI [1,2])
C3463824 (UMLS CUI [2])
C0087111 (UMLS CUI [2,1])
C2983796 (UMLS CUI [2,2])
C1514463 (UMLS CUI [1,2])
C0020402 (UMLS CUI [2])
C1514463 (UMLS CUI [1,2])
C0049065 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C0010711 (UMLS CUI [3,1])
C1514463 (UMLS CUI [3,2])
C1514463 (UMLS CUI [1,2])
C0008625 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C1504389 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C1504389 (UMLS CUI [2])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])